Innovent Biologics, Inc.

Innovent Biologics, Inc. is a biopharmaceutical company engaged in the development, manufacturing, and commercialization of medicines. The company's primary focus lies in the area of oncology, autoimmunity, metabolic, and ophthalmology diseases, aiming to address unmet medical needs. With a robust pipeline of drug candidates, Innovent Biologics has secured strategic collaborations with global pharmaceutical companies to enhance its research and development capabilities. The company operates mainly in China's expansive healthcare market, which is known for its growing demand for innovative treatments. Innovent Biologics contributes significantly to the biopharmaceutical sector by leveraging advanced technologies and research excellence, positioning itself as a leader in developing high-quality, affordable medicines. Founded in 2011 and headquartered in Suzhou, China, Innovent Biologics plays a vital role in shaping the landscape of healthcare solutions both domestically and internationally. Through its dedication to innovative practices, the company has gained recognition in the scientific community and continues to make strides in the advancement of biologics and biosimilars.